Category: Antibody Technologies
Global Antibody Technologies
-
Primary Immunodeficiency Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others), By Product (Immunoglobulin Replacement Therapy, Stem Cell/Bone Marrow Transplantation, Antibiotic Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Primary Immunodeficiency Therapeutics market size is poised to register 7.55% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Follicular Lymphoma Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Chemotherapy, Radiotherapy, Monoclonal Antibodies, Stem Cell Transplantation), By Application (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 6.91% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Follicular Lymphoma Therapeutics market By Type ... Read More
-
Global Immunoprecipitation Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Upstream Bioprocessing Market - By Product (Bioreactors/Fermenters, Cell Culture Products, Filters), Usage Mode (Multi-use, Single-use), Mode (In-house, Outsourced), Application (Monoclonal Antibody, Vaccine Production), End-user - Global Forecast, 2024 - 2032
... projected to expand at 9.7% CAGR from 2024 to 2032. Rapid advancements in biotechnology and genetic engineering are driving the development of novel biopharmaceuticals, subsequently accelerating the demand for upstream bioprocessing solutions. The growing prevalence ... Read More
-
Host Cell Protein Testing Market Research Report Forecast till 2032
... advancements in the biopharmaceutical business are driving business sector development. The host Cell Protein testing market is supposed to observe hearty development during the conjecture time frame, driven by elements, for example, expanding interest for ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Monoclonal antibodies (mAbs) Biosimilars industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal antibodies (mAbs) Biosimilars. The report ... Read More
-
Gonorrhea Diagnostic Market Size, Trends, Analysis, and Outlook By Type (Molecular Diagnostics Tests, Flow Cytometry, Diagnostic Imaging, Liposomes, Artificial Intelligence, Gel Micro-droplets, Chromatography, Differential Light Scattering, Monoclonal Antibodies), by Region, Country, Segment, and Companies, 2024-2030
... The global Gonorrhea Diagnostic market size is poised to register 8.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gonorrhea Diagnostic market ... Read More
-
Cancer Biological Therapy Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Cancer growth Blockers, Monoclonal Antibodies, Blood Cell Growth Factors, Gene Therapy), By Cancer (Pancreatic Cancer, Lung Cancer, Blood Cancer, Colorectal Cancer, Others), By Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Specialized cancer treatment centers, Hospitals Pharmacies, Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Cancer Biological Therapy market size is poised to register 7.88% growth from 2024 to 2030, presenting ... Read More
-
Research grade Proteins Market Size, Trends, Analysis, and Outlook By Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Others), By Host Cell, Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030
... & Fungi, Insect Cells, Others), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Research grade Proteins market size is poised to register 17.3% ... Read More
-
Research Antibodies Market Size, Trends, Analysis, and Outlook By Product(Primary Antibodies, Secondary Antibodies), By Type(Monoclonal Antibodies,Polyclonal Antibodies), By Technology(Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source(Mouse, Rabbit, Goat, Others), By Application(Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 The global Research Antibodies market size is poised to register ... Read More
-
Veterinary Orthopedic Medicine Market Size, Trends, Analysis, and Outlook By Product Type (Biologics (Stem Cells, Platelet-Rich Plasma (PRP), Monoclonal Antibody, Viscosupplements), Pharmaceuticals (Steroids, NSAIDS, Others)), By Animal Type (Canine, Feline, Equine, Cattle, Swine, Others), By Application (Osteoarthritis, Degenerative Joint Disease, Joint Inflammation/Pain, Others), By Route of Administration (Oral, Parenteral, Topical), By End-user ( Veterinary Hospitals, Veterinary Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (Osteoarthritis, Degenerative Joint Disease, Joint Inflammation/Pain, Others), By Route of Administration (Oral, Parenteral, Topical), By End-user ( Veterinary Hospitals, Veterinary Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Veterinary Orthopedic Medicine ... Read More
-
Global HER2 Antibodies Market Growth (Status and Outlook) 2024-2030
... downstream market, the HER2 Antibodies is forecast to a readjusted size of US$ 11550 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Immunoprotein Diagnostic Testing Market Size, Trends, Analysis, and Outlook By Test (Complement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests, C-Reactive Protein (CRP) Diagnostic Tests), By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin Technologies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Ion Channel Modulators
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Protein Labeling Reagents
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Radioimmunoassays
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for AntiCD20 Monoclonal Antibodies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
